Literature DB >> 10712885

The interaction between p53 and papillomaviruses.

F Mantovani1, L Banks.   

Abstract

The p53 tumour suppressor is one of the host's principal defences against viral replication and subsequent cell transformation. The human papillomaviruses have evolved an elaborate strategy whereby the viral E6 proteins directly target p53 for ubiquitin mediated degradation and thus overcome the inhibitory effects of p53. However, a more detailed picture of the HPV*b1p53 interaction is now emerging in which there is a complex interplay between both positive and negative effectors of these interactions. This demonstrates the existence of a finely balanced virus*b1host relationship which, on rare occasion, fails and initiates the processes that ultimately lead to malignancy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10712885     DOI: 10.1006/scbi.1999.0142

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  10 in total

1.  Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.

Authors:  S T Oh; S Kyo; L A Laimins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos.

Authors:  I Stancheva; C Hensey; R R Meehan
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

3.  HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.

Authors:  Benyue Zhang; Anjaiah Srirangam; David A Potter; Ann Roman
Journal:  Oncogene       Date:  2005-04-07       Impact factor: 9.867

4.  Molecular detection of Papillomavirus and immunohistochemical investigation of p53 gene expressions in bovine papillomas and fibropapillomas.

Authors:  Karakurt Emin; Coskun Nuvit; Dag Serpil; Beytut Enver; Veysel Soydal Ataseven; Yilmaz Volkan; Dogan Fırat; Nuhoglu Hilmi; Ermutlu Celal Sahin; Aydin Ugur; Kuru Mushap; Yildiz Ayfer
Journal:  Arch Microbiol       Date:  2022-04-24       Impact factor: 2.552

5.  Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population.

Authors:  Mohammad Farhadi; Zahra Tahmasebi; Shahin Merat; Farin Kamangar; Dariush Nasrollahzadeh; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

6.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.

Authors:  Ivan Martinez; Jun Wang; Kenosha F Hobson; Robert L Ferris; Saleem A Khan
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

7.  Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.

Authors:  Stephen T Oh; Michelle S Longworth; Laimonis A Laimins
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation.

Authors:  Lamech M Mwapagha; Nicki Tiffin; M Iqbal Parker
Journal:  Front Oncol       Date:  2017-11-01       Impact factor: 6.244

9.  Inferring Virus-Host relationship between HPV and its host Homo sapiens using protein interaction network.

Authors:  Qurat Ul Ain Farooq; Zeeshan Shaukat; Tong Zhou; Sara Aiman; Weikang Gong; Chunhua Li
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

Review 10.  Role of the ubiquitin system and tumor viruses in AIDS-related cancer.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.